Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from Pediatric Endocrinology of North Texas - Episode 2

T1D Staging: The Clinical Importance of Early Recognition

August 2, 2024

Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, Amy Burton, MD, Kathryn Springfield, PA-C, Deborah Shenkman, RDLD, CDCES

The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.

EP. 1: Navigating T1D: Mitigating Burden and Monitoring Disease Progression

EP. 2: T1D Staging: The Clinical Importance of Early Recognition

EP. 3: Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care

EP. 4: T1D Antibody Screening: Identifying High-Risk Populations

EP. 5: Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression

EP. 6: TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data

EP. 7: Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences

EP. 8: Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview

EP. 9: Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process

EP. 10: Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab